Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

Reclaiming Britain: The nation against ethno-nationalism
How can progressives respond to the increasing ethnonationalist narratives of the political right?
Rule of the market: How to lower UK borrowing costs
The UK is paying a premium on its borrowing costs that ‘economic fundamentals’, such as the sustainability of its public finances, cannot fully explain.
Restoring security: Understanding the effects of removing the two-child limit across the UK
The government’s decision to lift the two-child limit marks one of the most significant changes to the social security system in a decade.